Study: CorMatrix's biomaterial reduces risk of atrial fibrillation
This article was originally published in Clinica
Executive Summary
CorMatrix Cardiovascular's extracellular matrix (ECM) biomaterial could reduce the risk of atrial fibrillation when used for pericardial reconstruction, a study has suggested.